Diagnosis and Management of Polycystic Ovary Syndrome in Adolescents
暂无分享,去创建一个
[1] X. Ruan,et al. Why does Polycystic Ovary Syndrome (PCOS) Need Long-term Management? , 2019, Current pharmaceutical design.
[2] L. Kimble,et al. A mixed-methods study of coping and depression in adolescent girls with polycystic ovary syndrome , 2019, Journal of the American Association of Nurse Practitioners.
[3] H. Randeva,et al. Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis , 2019, Systematic Reviews.
[4] Z. Asemi,et al. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome , 2019, Journal of Ovarian Research.
[5] S. Atkin,et al. Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome , 2018, Therapeutic advances in endocrinology and metabolism.
[6] A. Dokras,et al. Beyond fertility: polycystic ovary syndrome and long-term health. , 2018, Fertility and sterility.
[7] N. Nader,et al. A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[8] L. Redman,et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome , 2018, Clinical endocrinology.
[9] Madhu Jain,et al. Effect of Orlistat Versus Metformin in Various Aspects of Polycystic Ovarian Syndrome: A Systematic Review of Randomized Control Trials , 2018, The Journal of Obstetrics and Gynecology of India.
[10] Durgesh Gupta,et al. Comparison of Metformin and N Acetylcysteine on Clinical, Metabolic Parameter and Hormonal Profile in Women with Polycystic Ovarian Syndrome , 2018, The Journal of Obstetrics and Gynecology of India.
[11] X. Ruan,et al. Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[12] K. Ong,et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence , 2017, Hormone Research in Paediatrics.
[13] R. Fanchin,et al. Dysregulation of the Anti‐Müllerian Hormone System by Steroids in Women With Polycystic Ovary Syndrome , 2017, The Journal of clinical endocrinology and metabolism.
[14] J. Sanfilippo,et al. Polycystic ovary syndrome in adolescents. , 2017, Best practice & research. Clinical obstetrics & gynaecology.
[15] K. Djafarian,et al. Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials. , 2017, Diabetes & metabolic syndrome.
[16] A. Siejka,et al. The pathogenesis and treatment of polycystic ovary syndrome: What's new? , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[17] F. Fang,et al. Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. , 2017, Complementary therapies in clinical practice.
[18] K. Curtis,et al. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review. , 2017, Contraception.
[19] M. Trent,et al. Treatment Considerations for the Cardiometabolic Signs of Polycystic Ovary Syndrome: A Review of the Literature Since the 2013 Endocrine Society Clinical Practice Guidelines. , 2016, JAMA pediatrics.
[20] S. Milla,et al. Is ultrasound useful in the diagnosis of adolescents with polycystic ovary syndrome? , 2015, Journal of pediatric endocrinology & metabolism : JPEM.
[21] B. Saleh,et al. The role of anti-Mullerian hormone and inhibin B in the assessment of metformin therapy in women with polycystic ovarian syndrome , 2015, Saudi medical journal.
[22] L. Gathercole,et al. Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome , 2015, The Lancet.
[23] B. Viollet,et al. Metformin: from mechanisms of action to therapies. , 2014, Cell metabolism.
[24] R. Pasquali,et al. Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome. , 2014, European journal of endocrinology.
[25] M. Murad,et al. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline , 2013, The Journal of clinical endocrinology and metabolism.
[26] Shunping Wang,et al. Racial and Ethnic Differences in Physiology and Clinical Symptoms of Polycystic Ovary Syndrome , 2013, Seminars in Reproductive Medicine.
[27] H. Teede,et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. , 2013, Human reproduction.
[28] W. Kraus,et al. Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome. , 2009, Medicine and science in sports and exercise.
[29] J. Stark,et al. Follicle dynamics and anovulation in polycystic ovary syndrome. , 2008, Human reproduction update.
[30] J. Marshall,et al. Polycystic Ovary Syndrome in Adolescence , 2008, Annals of the New York Academy of Sciences.
[31] M. Trent,et al. Effects of polycystic ovary syndrome on health-related quality of life , 2007, Expert review of pharmacoeconomics & outcomes research.
[32] R. Azziz,et al. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. , 2005, The Journal of clinical endocrinology and metabolism.
[33] S. Vesely,et al. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. , 2005, The Journal of clinical endocrinology and metabolism.
[34] M. Trent,et al. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. , 2005, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.
[35] E. Battle,et al. Laser‐assisted hair removal for darker skin types , 2004, Dermatologic therapy.
[36] R. Deutsch,et al. Relationship of GnRH‐stimulated LH release to episodic LH secretion and baseline endocrine‐metabolic measures in women with polycystic ovary syndrome , 2004, Clinical endocrinology.
[37] J. Stark,et al. Formation and early development of follicles in the polycystic ovary , 2003, The Lancet.
[38] M. Trent,et al. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. , 2003, Journal of pediatric and adolescent gynecology.
[39] R. Legro,et al. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. , 1999, Molecular endocrinology.
[40] Ahmed Zaheer,et al. A comparison of current acne grading systems and proposal of a novel system , 1997, International journal of dermatology.
[41] S. Franks,et al. Polycystic ovary syndrome. , 1995, Archives of disease in childhood.
[42] K. Segal,et al. Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome , 1992, Diabetes.
[43] S. Jean Emans,et al. Pediatric and adolescent gynecology , 1992 .
[44] Dolian Gg,et al. Diagnostic criteria for polycystic ovary syndrome , 1989 .
[45] S. Evron,et al. A novel use of spironolactone: treatment of hirsutism. , 1980, The Journal of clinical endocrinology and metabolism.
[46] D. Ferriman,et al. Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.
[47] T. Bednarczuk,et al. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients. , 2017, Ginekologia polska.
[48] A. Atkinson,et al. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate. , 2001, QJM : monthly journal of the Association of Physicians.
[49] D. Ehrmann,et al. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. , 2000, Journal of pediatric endocrinology & metabolism : JPEM.
[50] R. Pasquali,et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. , 1989, The Journal of clinical endocrinology and metabolism.